Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/29/1995 | CA1336810C Synergistic interplay of lymphokines and double stranded rnas |
08/26/1995 | CA2143251A1 Tricyclic derivative, its use in the preparation of drugs for the treatment of mnemonic-cognitive disorders |
08/26/1995 | CA2142376A1 Iontophoretic transdermal delivery of deoxyspergualin compounds |
08/25/1995 | CA2143412A1 Imidazopyridine derivatives as angiotensin ii antagonists |
08/24/1995 | WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy |
08/24/1995 | WO1995022617A1 Host-vector system for use in gene therapy |
08/24/1995 | WO1995022611A2 Methods and compositions for stimulating bone cells |
08/24/1995 | WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof |
08/24/1995 | WO1995022604A1 Rna editing enzyme and methods of use thereof |
08/24/1995 | WO1995022553A1 Oligonucleotides with anti-respiratory syncytial virus activity |
08/24/1995 | WO1995022552A1 Antiparasitic agents |
08/24/1995 | WO1995022551A1 1-(2'-hydroxy- and 2'-sulphatoalkyl)glycosides |
08/24/1995 | WO1995022550A1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents |
08/24/1995 | WO1995022549A1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
08/24/1995 | WO1995022548A1 Tricyclic spiropiperidines |
08/24/1995 | WO1995022546A1 Intracellular signalling mediators |
08/24/1995 | WO1995022545A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
08/24/1995 | WO1995022542A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists |
08/24/1995 | WO1995022541A1 Enantiomerically pure(-)-liarozole |
08/24/1995 | WO1995022540A1 Enantiomerically pure (+)-liarozole |
08/24/1995 | WO1995022538A1 5-substituted derivatives of mycophenolic acid |
08/24/1995 | WO1995022537A2 4-amino derivatives of 5-substituted mycophenolic acid |
08/24/1995 | WO1995022536A1 6-substituted mycophenolic and derivatives with immunosuppressive activity |
08/24/1995 | WO1995022535A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity |
08/24/1995 | WO1995022534A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
08/24/1995 | WO1995022529A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
08/24/1995 | WO1995022528A1 2-(4-methoxyphenoxy)-3-pyridineamine, its preparation and its use as anti-inflammatory agent |
08/24/1995 | WO1995022524A1 Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
08/24/1995 | WO1995022520A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors |
08/24/1995 | WO1995022351A1 Composition for topical application |
08/24/1995 | WO1995022345A1 A method and agents for control and management of labor during pregnancy |
08/24/1995 | WO1995022341A1 Labelled peptide compounds |
08/24/1995 | WO1995022340A1 Methods for altering fertility |
08/24/1995 | WO1995022334A1 Postmenopausal hormonal treatment agent and process using gestagens only, then gestagens associated with oestrogens |
08/24/1995 | WO1995022333A1 Process for producing a sterile prednisolone gel |
08/24/1995 | WO1995022332A1 Postmenopausal hormone substitution product and process |
08/24/1995 | WO1995022331A1 Aqueous indolocarbazole solutions |
08/24/1995 | WO1995022330A1 Antiviral agents |
08/24/1995 | WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
08/24/1995 | WO1995022327A1 Use of 1-(arylalkylaminoalkyl) imidazoles for treating neurological damage |
08/24/1995 | WO1995022326A1 Cholinesterase activator |
08/24/1995 | WO1995022325A1 Compositions containing micronized nebivolol |
08/24/1995 | WO1995022324A1 Treatment of migraine headaches and formulations |
08/24/1995 | WO1995022323A1 Methods for controlling free radical generation by inflammatory cells |
08/24/1995 | WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems |
08/24/1995 | WO1995022321A1 Desogestrel-containing transdermal application agent |
08/24/1995 | WO1995022320A1 Ranitidine solid dosage form |
08/24/1995 | WO1995022318A1 Drugs, vaccines and hormones in polylactide coated microspheres |
08/24/1995 | WO1995022259A1 Improving growth and lactation of ruminants |
08/24/1995 | DE4405899A1 Mittel zur transdermalen Applikation enthaltend Desogestrel Means for transdermal administration comprising desogestrel |
08/24/1995 | DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids |
08/24/1995 | DE4405641A1 2-(4-Methoxyphenoxy)-3-pyridinamin, dessen pharmazeutische Zusammensetzungen und dessen Verwendung zur Herstellung eines Arzneimittels 2- (4-methoxyphenoxy) -3-pyridinamine, its pharmaceutical compositions and its use for the manufacture of a medicament |
08/24/1995 | CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy |
08/24/1995 | CA2183571A1 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
08/24/1995 | CA2183565A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
08/24/1995 | CA2183562A1 Intracellular signalling mediators |
08/24/1995 | CA2183544A1 Desogestrel-containing transdermal application agent |
08/24/1995 | CA2183539A1 Treatment of migraine headaches and formulations |
08/24/1995 | CA2183533A1 6-substituted mycophenolic acid and derivatives |
08/24/1995 | CA2183532A1 4-amino 6-substituted mycophenolic acid and derivatives |
08/24/1995 | CA2183531A1 4-amino derivatives of 5-substituted mycophenolic acid |
08/24/1995 | CA2183530A1 5-substituted derivatives of mycophenolic acid |
08/24/1995 | CA2183529A1 4-amino derivatives of mycophenolic acid |
08/24/1995 | CA2183421A1 Labelled peptide compounds |
08/24/1995 | CA2183418A1 Improving growth and lactation of ruminants |
08/24/1995 | CA2183269A1 1-(2'-hydroxy- and 2'-sulphatoalkyl)glycosides |
08/24/1995 | CA2183253A1 Rna editing enzyme and methods of use thereof |
08/24/1995 | CA2182882A1 Cholinesterase activator |
08/24/1995 | CA2182792A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors |
08/24/1995 | CA2182733A1 Tricyclic spiropiperidines |
08/24/1995 | CA2182583A1 Enantiomerically pure (+)-liarozole |
08/24/1995 | CA2181546A1 Oligonucleotides with anti-respiratory syncytial virus activity |
08/24/1995 | CA2181542A1 2-(4-methoxyphenoxy)-3-pyridineamine, its preparation and its use as anti-inflammatory agent |
08/23/1995 | EP0668357A1 Vector for integration site independent gene expression in mammalian host cells |
08/23/1995 | EP0668351A1 Erythropoietin isoforms |
08/23/1995 | EP0668281A1 Acronycin analogues, process for their preparation and pharmaceutical compositions containing them |
08/23/1995 | EP0668279A2 6-Azaindole thromboxane synthase inhibitors |
08/23/1995 | EP0668278A1 Adhesion receptor antagonists |
08/23/1995 | EP0668274A1 Sulfonamidodioxepanes with hypoglycermic activity, methods of preparation, intermediates and salts thereof |
08/23/1995 | EP0668273A1 Derivatives of 1-2-(1H-inden-3-yl)ethyl-4-(naphtalen-1-yl)-piperazin, their preparation and their therapeutical use |
08/23/1995 | EP0668270A2 2-Imidazoline-5-ones derivatives as fungicides |
08/23/1995 | EP0668268A2 Bicyclolactam derivatives for improving cerebral functions |
08/23/1995 | EP0668076A1 Stabilization of a prostanoic acid compound |
08/23/1995 | EP0668075A2 Non-peptide tachykinin receptor antagonists |
08/23/1995 | EP0668074A1 Pharmaceutical composition |
08/23/1995 | EP0667922A1 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same |
08/23/1995 | EP0667914A1 Fo-1289 substance and its production |
08/23/1995 | EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy |
08/23/1995 | EP0667867A1 Piperidine derivatives as 5-ht4 receptor antagonists |
08/23/1995 | EP0667866A1 1,4-benzothiazepines useful as neurological agents |
08/23/1995 | EP0667860A1 Aza spiro alkanes derivatives as therapeutic agents |
08/23/1995 | EP0667858A1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists |
08/23/1995 | EP0667857A1 Indolylcarbamates as anti-inflammatory agents |
08/23/1995 | EP0667856A1 Novel vitamin d analogues |
08/23/1995 | EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
08/23/1995 | EP0667852A1 Novel 3,3-diphenylpropylamines, their use and preparation |
08/23/1995 | EP0667792A1 Specific tolerance in transplantation |
08/23/1995 | EP0667791A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
08/23/1995 | EP0667779A1 Ophthalmic solution and method of use |
08/23/1995 | EP0667778A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene |